Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Alliqua BioMedical, Inc. (ADYX) had Normalized Income after Taxes of $-7.00M for the most recently reported fiscal year, ending 2018-12-31.
| Income Statement Financials | |
$2.22M |
|
$-8.42M |
|
$1.72M |
|
$0.50M |
|
$7.51M |
|
$-5.30M |
|
$-1.71M |
|
$-7.00M |
|
$-7.00M |
|
$-7.00M |
|
$-7.00M |
|
$-8.42M |
|
|
Normalized Income after Taxes |
$-7.00M |
$-5.30M |
|
$-3.18M |
|
0.82M |
|
0.82M |
|
$-10.26 |
|
$-10.26 |
|
| Balance Sheet Financials | |
$9.30M |
|
$0.20M |
|
$0.38M |
|
$9.68M |
|
$1.38M |
|
-- |
|
$0.05M |
|
$1.43M |
|
$8.25M |
|
$8.25M |
|
$8.25M |
|
0.83M |
|
| Cash Flow Statement Financials | |
$-9.71M |
|
$29.30M |
|
$-12.89M |
|
$2.18M |
|
$8.88M |
|
$6.70M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
22.38% |
|
-238.99% |
|
-238.99% |
|
-143.59% |
|
-316.06% |
|
-379.83% |
|
$-9.71M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
17.03 |
|
65.18 |
|
5.60 |
|
-84.88% |
|
-84.88% |
|
-72.36% |
|
-84.88% |
|
$9.89 |
|
$-11.83 |
|
$-11.83 |
|